Home › NCT06314672

Outreach Project to Connect Underrepresented Populations to Clinical Trials at Ohio State University, CUSP2CT Project Trial

The Ohio State University Connecting Underrepresented Populations to Clinical Trials (CUSP2CT) Project

Who can join

All ages · All sexes · Healthy volunteers welcome

Inclusion Criteria:

* Phase I: 9 counties in the OSUCCC catchment area
* Phase II: Patients, providers, and hospital systems/referral centers that directly addresses challenges identified in Phase I
* Phase II: The project will involve the OSUCCC, the OSU James Cancer Network sites and the Columbus and Dayton NCORP sites

About the study

This clinical trial tests the impact of the The Ohio State University Connecting Underrepresented Populations to Clinical Trials (CUSP2CT) project on clinical trial referrals and enrollment in racial/ethnic minorities. Progress in cancer prevention, detection and treatment can only be made by identifying and validating new and improved methods, compounds and modalities in clinical trials. Unfortunately, participation in clinical trials is not equal across all racial and ethnic groups, limiting progress against cancer in all population groups and further widening the disparity gap. To change this picture, concerted effort needs to be directed both at the communities at risk for being left out of trials and the systems that cause the disparities at all levels involved in accrual to clinical trials. The CUSP2CT project may have the potential to increase referral and accrual of racial/ethnic minorities to prevention/control and treatment trials.

What is being tested

• Accrual (procedure)
• Discussion (procedure)
• Educational Activity (other)
• Interview (other)
• Review (other)
• Survey Administration (other)

Sponsor: Ohio State University Comprehensive Cancer Center · Participants: 208 · Started: Aug 22, 2023

Contact the study team

• The Ohio State Comprehensive Cancer Center · Phone: 800-293-5066

Official record on ClinicalTrials.gov — NCT06314672

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.